(secondQuint)Preoperative Intratumor Dendritic Cells Injection Immunotherapy for Patients With Pancreatic Cancer.

 The prognosis of pancreatic cancer is extremely poor even with extensive surgery, and development of new treatment modalities is much-expected for cure of this disease.

 Dendritic cells (DCs) immunotherapy is expected favorable outcome when it is approached directly to the cancer tissue.

 To evaluate safety and immunological responses, we conducted a phase I/II study of intra-tumor DCs immunotherapy for pancreatic cancer patients.

.

 Preoperative Intratumor Dendritic Cells Injection Immunotherapy for Patients With Pancreatic Cancer@highlight

The purpose of this study is to confirm safety and immunological responses of Preoperative intratumor dendritic cells injection immunotherapy using immature dendritic cells with S pyogenes Preparation (OK-432) for patients with resectable pancreatic cancer for pancreatic cancer patients.

